Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017)

Bio-Rad Laboratories (BIO) posted quarterly Deferred Taxes of -$5.3 million for Q3 2017, down 142.66% year-over-year from $12.5 million in Q3 2016, and down 284.83% quarter-over-quarter from $2.9 million in Q2 2017.

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Deferred Taxes for 3 consecutive years, with -$5.3 million the latest figure, recorded in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 107.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 17.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -181.30 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -300,000.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 235.96 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 600,000.00
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.35 Mn
Jun 30, 2017 2.89 Mn
Mar 31, 2017 163,000.00
Sep 30, 2016 12.54 Mn
Jun 30, 2016 -666,000.00
Mar 31, 2016 -3.39 Mn
Sep 30, 2015 -2.73 Mn